Cargando…

NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study

BACKGROUND: The prognostic significance of the amino-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) in patients with ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) has not been fully elucidated. Major adverse cardiova...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Zuoan, Du, Yaoyao, Zhou, Quan, Lu, Xuelin, Luo, Li, Zhang, Zhixiang, Guo, Ning, Ge, Liangqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577951/
https://www.ncbi.nlm.nih.gov/pubmed/34765262
http://dx.doi.org/10.1155/2021/9943668
_version_ 1784596170147889152
author Qin, Zuoan
Du, Yaoyao
Zhou, Quan
Lu, Xuelin
Luo, Li
Zhang, Zhixiang
Guo, Ning
Ge, Liangqing
author_facet Qin, Zuoan
Du, Yaoyao
Zhou, Quan
Lu, Xuelin
Luo, Li
Zhang, Zhixiang
Guo, Ning
Ge, Liangqing
author_sort Qin, Zuoan
collection PubMed
description BACKGROUND: The prognostic significance of the amino-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) in patients with ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) has not been fully elucidated. Major adverse cardiovascular events (MACEs) are clinically viable indicators for the accurate, rapid, and safe evaluation of patients with STEMI. This study was designed to investigate the relationship between NT-proBNP levels and the occurrence of short-term MACEs in patients with STEMI who underwent emergency PCI. METHODS: This prospective cohort study included 405 patients with STEMI aged 20–90 years who underwent emergency PCI at the First People's Hospital of Changde City from April 6, 2017, to May 31, 2019. Stent thrombosis, reinfarction, congestive heart failure, unstable angina, and cardiac death were considered as MACEs in this study. The target-independent and -dependent variables were NT-proBNP at baseline and MACE, respectively. RESULTS: There were 28.25% of MACEs. Age, number of implanted stents, Killip class, infarction-related artery, applied intra-aortic balloon pump (IABP), creatine kinase (CK) peak value, CK-MB peak value, TnI peak value, and ST-segment resolution were independently associated with MACE (P < 0.05). In a multivariate model, after adjusting all potential covariates, Log2 NT-proBNP levels remained significantly associated with MACE, with an inflection point of 11.66. The effect sizes and confidence intervals of the left and right sides of the inflection point were 1.07 and 0.84–1.36 (P=0.5730) and 3.47 and 2.06–5.85 (P < 0.0001), respectively. CONCLUSIONS: In patients with STEMI who underwent PCI, Log2 NT-proBNP was positively correlated with MACE within 1 month when the Log2 NT-proBNP was >11.66 (NT-proBNP >3.236 pg/mL).
format Online
Article
Text
id pubmed-8577951
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85779512021-11-10 NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study Qin, Zuoan Du, Yaoyao Zhou, Quan Lu, Xuelin Luo, Li Zhang, Zhixiang Guo, Ning Ge, Liangqing Cardiol Res Pract Research Article BACKGROUND: The prognostic significance of the amino-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) in patients with ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) has not been fully elucidated. Major adverse cardiovascular events (MACEs) are clinically viable indicators for the accurate, rapid, and safe evaluation of patients with STEMI. This study was designed to investigate the relationship between NT-proBNP levels and the occurrence of short-term MACEs in patients with STEMI who underwent emergency PCI. METHODS: This prospective cohort study included 405 patients with STEMI aged 20–90 years who underwent emergency PCI at the First People's Hospital of Changde City from April 6, 2017, to May 31, 2019. Stent thrombosis, reinfarction, congestive heart failure, unstable angina, and cardiac death were considered as MACEs in this study. The target-independent and -dependent variables were NT-proBNP at baseline and MACE, respectively. RESULTS: There were 28.25% of MACEs. Age, number of implanted stents, Killip class, infarction-related artery, applied intra-aortic balloon pump (IABP), creatine kinase (CK) peak value, CK-MB peak value, TnI peak value, and ST-segment resolution were independently associated with MACE (P < 0.05). In a multivariate model, after adjusting all potential covariates, Log2 NT-proBNP levels remained significantly associated with MACE, with an inflection point of 11.66. The effect sizes and confidence intervals of the left and right sides of the inflection point were 1.07 and 0.84–1.36 (P=0.5730) and 3.47 and 2.06–5.85 (P < 0.0001), respectively. CONCLUSIONS: In patients with STEMI who underwent PCI, Log2 NT-proBNP was positively correlated with MACE within 1 month when the Log2 NT-proBNP was >11.66 (NT-proBNP >3.236 pg/mL). Hindawi 2021-11-02 /pmc/articles/PMC8577951/ /pubmed/34765262 http://dx.doi.org/10.1155/2021/9943668 Text en Copyright © 2021 Zuoan Qin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Qin, Zuoan
Du, Yaoyao
Zhou, Quan
Lu, Xuelin
Luo, Li
Zhang, Zhixiang
Guo, Ning
Ge, Liangqing
NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_full NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_fullStr NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_full_unstemmed NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_short NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_sort nt-probnp and major adverse cardiovascular events in patients with st-segment elevation myocardial infarction who received primary percutaneous coronary intervention: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577951/
https://www.ncbi.nlm.nih.gov/pubmed/34765262
http://dx.doi.org/10.1155/2021/9943668
work_keys_str_mv AT qinzuoan ntprobnpandmajoradversecardiovasculareventsinpatientswithstsegmentelevationmyocardialinfarctionwhoreceivedprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT duyaoyao ntprobnpandmajoradversecardiovasculareventsinpatientswithstsegmentelevationmyocardialinfarctionwhoreceivedprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT zhouquan ntprobnpandmajoradversecardiovasculareventsinpatientswithstsegmentelevationmyocardialinfarctionwhoreceivedprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT luxuelin ntprobnpandmajoradversecardiovasculareventsinpatientswithstsegmentelevationmyocardialinfarctionwhoreceivedprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT luoli ntprobnpandmajoradversecardiovasculareventsinpatientswithstsegmentelevationmyocardialinfarctionwhoreceivedprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT zhangzhixiang ntprobnpandmajoradversecardiovasculareventsinpatientswithstsegmentelevationmyocardialinfarctionwhoreceivedprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT guoning ntprobnpandmajoradversecardiovasculareventsinpatientswithstsegmentelevationmyocardialinfarctionwhoreceivedprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT geliangqing ntprobnpandmajoradversecardiovasculareventsinpatientswithstsegmentelevationmyocardialinfarctionwhoreceivedprimarypercutaneouscoronaryinterventionaprospectivecohortstudy